{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Pulmonary metastases from colorectal cancer"],"disease":["Pulmonary Metastases From Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2620003"],"location":["Japan"],"study_start_month":["8"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Pilot Study of chemotherapy with Capecitabine,Oxaliplatin and Bevacizumab for pulmonary metastases from colorectal cancer","description":"Interventions: Chemotherapy with XELOX(capecitabine+oxaliplatin)+bevacizumab Treatment repeats every 21days for up to 4courses\nPrimary outcome(s): safety\nStudy Design: Single arm Non-randomized","dates":{"creation":"2010-08-15"},"accession":"2620003","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000004556"]}}